Source: Clinical and Experimental Medicine. Unidade: FFCLRP
Subjects: NEOPLASIAS CEREBRAIS, ANTINEOPLÁSICOS
ABNT
MONTALDI, Ana P. e SAKAMOTO-HOJO, Elza Tiemi. Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide. Clinical and Experimental Medicine, v. 13, n. 4, p. 279-288, 2013Tradução . . Disponível em: https://doi.org/10.1007/s10238-012-0201-x. Acesso em: 02 maio 2024.APA
Montaldi, A. P., & Sakamoto-Hojo, E. T. (2013). Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide. Clinical and Experimental Medicine, 13( 4), 279-288. doi:10.1007/s10238-012-0201-xNLM
Montaldi AP, Sakamoto-Hojo ET. Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide [Internet]. Clinical and Experimental Medicine. 2013 ; 13( 4): 279-288.[citado 2024 maio 02 ] Available from: https://doi.org/10.1007/s10238-012-0201-xVancouver
Montaldi AP, Sakamoto-Hojo ET. Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide [Internet]. Clinical and Experimental Medicine. 2013 ; 13( 4): 279-288.[citado 2024 maio 02 ] Available from: https://doi.org/10.1007/s10238-012-0201-x